Brief overview of clinical evidence for homeopathic interventions in the management of COVID-19 patients

DMO Campos, MK Silva, GCF Morais, JFR Neto… - …, 2024 - thieme-connect.com
As of May 25th, 2023, 766 million COVID-19 cases and over 6.9 million deaths worldwide
had been reported to the World Health Organization. 1 In the pursuit of combating this global …

Longitudinal study across SARS-CoV-2 variants identifies transcriptionally active microbes (TAMs) associated with Delta severity

P Devi, P Kumari, A Yadav, B Tarai, S Budhiraja… - Iscience, 2023 - cell.com
Emergence of new SARS-CoV-2 VOCs jeopardize global vaccine and herd immunity
safeguards. VOCs interactions with host microbiota might affect clinical course and outcome …

Metagenomic insights into fungal community composition of the nasopharyngeal region of COVID‐19 associated mucormycosis patients from India

B Arunan, D Talukdar, S Swain… - Journal of Medical …, 2024 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) associated mucormycosis (CAM) was
reported predominantly from India during the second wave of COVID‐19 and has a high …

[HTML][HTML] Correlation Between Cryptococcus Infection and the Nasal Mycobiota in a Population of Free-Ranging Koalas (Phascolarctos cinereus) in New South Wales …

AS McPherson, SL Haworth, A Kan, LM de Miranda… - Journal of Fungi, 2025 - mdpi.com
Cryptococcosis is a fungal disease in humans and animals, caused by the Cryptococcus
neoformans and Cryptococcus gattii species complexes. Clinical cryptococcosis primarily …

[HTML][HTML] Influence of Mycobiota in the Nasopharyngeal Tract of COVID-19 Patients

V Folliero, C Ferravante, F Dell'Annunziata… - Microorganisms, 2024 - mdpi.com
The nasopharyngeal tract contains a complex microbial community essential to maintaining
host homeostasis. Recent studies have shown that SARS-CoV-2 infection changes the …